chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Bled a lot; Bruising; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE HAEMORRHAGE (Bled a lot) and VACCINATION SITE BRUISING (Bruising) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history.).    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jan-2021, the patient experienced VACCINATION SITE HAEMORRHAGE (Bled a lot) and VACCINATION SITE BRUISING (Bruising). At the time of the report, VACCINATION SITE HAEMORRHAGE (Bled a lot) and VACCINATION SITE BRUISING (Bruising) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Moderate headache, moderate nausea, moderate soreness in upper arm of injection site Lasted 2 1/2 days Ibuprofen Eventually dissapeared
84 yo F was admitted to hospital with concern re uti and was found to have significant b/l hydronephrosis and constipation. She had stent placement and disimpaction in OR per urology and improved. She was treated for abx per cultures and doing well. D/w daughter and concerned re iron supp causing bad constipation and is stopped and discussed to get iron infusion setup as outpt. She was discharged back to assisted living facility with hhc in stable condition.
on 2/11/2021 AT 5:30pm  Evening of the vaccination, my neck aching, and slight headache, When I woke the next day my arms and legs and neck and head ached, like I was coming down with a flu bug. Slight headache, Lymph nodes in neck painful and sore, legs and arms aching, flu like symptoms
This is a spontaneous report from a contactable pharmacist. A patient of unspecified age, ethnicity and gender received a single dose of TRUMENBA intramuscular in the arm on an unspecified date. The patient medical history and concomitant medications were not reported. On an unspecified date the patient experienced redness (the reaction was around the back of the arm and not right at the site of injection). The outcome was unknown. Follow-up (14OCT2016): Follow-up attempts are completed. No further information is expected.
p/vax pt exp pain at inj site; devel rash on legs; consisted of lines running up anterior of both legs from ankle to thigh; appeared like contact dermatitis;tx: allegra
This case was reported by a pharmacist via call center representative and described the occurrence of loss of consciousness in a female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced loss of consciousness (serious criteria GSK medically significant). On an unknown date, the outcome of the loss of consciousness was recovered/resolved.  It was unknown if the reporter considered the loss of consciousness to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The healthcare professional (HCP) said that her cousin received SHINGRIX and said she was knocked out for 2 days.
pt became fussy immed p/inject; father noticed pt had dilated pupils w/nystagmus & appeared jerky; pt no longer track w/eyes & noted facial tremor; pt conts to be w/dilated pupils w/odd head movements;irritable
She screamed immediately and continued to do so for 10 minutes. None of my other children have ever done this. That night she had redness/bumps at injection site. It's been over 2 weeks and she has divets where the vaccines were administered and hard lumps that we've tried rubbing in for absorption. The lumps are still there and still really hard.
Nine days after shot, injection site turns sore, red, itchy, and irritated.   Hadn't been even sore since Day 2.    Daily VCheckin had been discontinued.
Patient called me today (10/27/11 @ 4:08pm) stating that she received the flu shot on 10/19/11. After she received the flu shot, she stated that she developed a rash around the area the flu shot was administered (left deltoid) and the rash has since spread to both arms and legs.  She has never had any prior reaction to the flu vaccination and is not allergic to egg or egg protein.  She has received medical attention from her primary care physician.
left arm fell asleep/left side of her body became numb/shoulder and back numb; Did not receive the second dose; right shoulder still hurts; tingling from head to toe that progressed with a month of first dose; swelling in right arm; immediate feeling of itchiness as soon as shot went in her arm; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HYPOAESTHESIA (left arm fell asleep/left side of her body became numb/shoulder and back numb), PARAESTHESIA (tingling from head to toe that progressed with a month of first dose), PERIPHERAL SWELLING (swelling in right arm), PRURITUS (immediate feeling of itchiness as soon as shot went in her arm) and PRODUCT DOSE OMISSION ISSUE (Did not receive the second dose) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included METOPROLOL and OMEPRAZOLE for an unknown indication.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced PARAESTHESIA (tingling from head to toe that progressed with a month of first dose), PERIPHERAL SWELLING (swelling in right arm) and PRURITUS (immediate feeling of itchiness as soon as shot went in her arm). On an unknown date, the patient experienced HYPOAESTHESIA (left arm fell asleep/left side of her body became numb/shoulder and back numb), PRODUCT DOSE OMISSION ISSUE (Did not receive the second dose) and ARTHRALGIA (right shoulder still hurts). The patient was treated with IBUPROFEN at a dose of UNK dosage form. At the time of the report, HYPOAESTHESIA (left arm fell asleep/left side of her body became numb/shoulder and back numb), PARAESTHESIA (tingling from head to toe that progressed with a month of first dose), PERIPHERAL SWELLING (swelling in right arm), PRURITUS (immediate feeling of itchiness as soon as shot went in her arm) and PRODUCT DOSE OMISSION ISSUE (Did not receive the second dose) outcome was unknown and ARTHRALGIA (right shoulder still hurts) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-May-2021, Magnetic resonance imaging: No results provided..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient was scheduled for nerve conduction and had appointment with neurologist. No treatment was prescribed because doctors were not sure of the cause of the symptoms. Doctor advised the patient to hold off on second dose. The reporter mentioned that the treatment included Ibuprofen.
Due to "covid and other things", received the second dose  in February 2022; This case was reported by a pharmacist via call center representative and described the occurrence of social problem in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose in January 2021).   In February 2022, the patient received the 2nd dose of Shingrix. In February 2022, unknown after receiving Shingrix, the patient experienced social problem. On an unknown date, the outcome of the social problem was unknown.   Additional Information: GSK Receipt Date: 10-MAY-2022 Reporter's Comments: The pharmacist reported that a patient was late for the second dose of Shingrix, because of the COVID situation and other things.  The pharmacist did not want to provide more information.  Consent to follow up could not be asked. Additional Supportive Information: The pharmacist reported that a patient was late for the second dose of Shingrix, because of the COVID situation and other things, which led to social problem.
Lower back pain (continuous as of today however less than before), fatigue (7 days), mid-chest pain (1.5 days), intermittent dull pulse pain?right leg calf (continuous)
Pt c/o nausea 15 mins after receiving vaccine. She denied chest pain, SOB, difficulty breathing, or other complaints. Past med hx as reported by patient is carotid artery disease. Pt assessed and evaluated by NP and paramedic. Pt had mild anxiety, BP - 157/80.
Pt received vaccines (FLUZONE high dose and PREVNAR 13) on 10/8/15 and on 10/19/15 pt stated he is still having pain and itching. (L) arm noted with swelling and redness down to elbow.
pt had onset of sz activity x2 w/fever approx 18hr p/vax;
Pt recvd DTP/OPV/HIB on 16JAN92 @ 550PM; @ 7PM mom noted fever 102.8 & shaking of arms & legs of pt-4 episodes; @ ER febrile seizure secondary to DTP vax dxd; tx APAP;
On about 11/14/2022, I was extremely tired and had general malaise. I took a home antigen test that day and got a negative result. I took it again about 11/15/2022 and got a positive result. I then underwent a PCR test that day, and it also yielded a positive result. I called my doctor and notified her of the situation. At that point, I didn't have a fever. The only symptoms I had were sinus congestion and runny nose.  My doctor recommended that I take vitamin B3, vitamin C, and another supplement whose name escapes me. I continued to test positive for COVID-19 for two weeks afterwards. I finally tested negative around 12/5/2022. I went to an ENT on 3/8/2023, because I continued to have sinus congestion and fullness in the ear. The ENT diagnosed me with sinusitis and prescribed me amoxicillin/clavulanic acid, which I was to take for 21 days. This seems to have helped, because I feel fine now. On 4/13/2023, I underwent a CT scan of my sinuses, because my ENT wanted to see if my sinuses had cleared up or if I had a serious condition. The results indicated that my sinuses were clear.
Patient self-reported through the hospital. In her own words, "After 2nd dose of Pfizer COVID-19 Vaccine 1/15/21 @ 0630, at 2030 developed generalized aching, chills, weakness and sleepiness.  Woke up at 0300, went to bathroom and passed out returning to bed.  Awakened soaked in perspiration.  Had dry heaves and 1 loose stool.  Felt weak and sleepy until 0700, then felt mostly normal.  Symptoms relieved by 1000.  No other symptoms after that".
This spontaneous report was received from a certified medical assistant concerning to an unspecified number of patients of unknown age and gender. No medical history or concurrent conditions were reported. On an unspecified date in January 2015, also reported a s 09-JAN-2015, an unspecified number of patients were vaccinated with VARIVAX (Merck), subcutaneously (dose, strength, frequency and lot number were not provided) which underwent supported temperature excursions. Co-suspect or concomitant therapies were not provided. No adverse effects were reported. This is one of several reports from the same source. Additional information has been requested.
Strawberry rash under breast, no symptoms, localized, not diffuse.  Almost gone after 24 days.
Pt was given Pneumovax per Dr.'s verbal order.  This would be 3rd dose, previous administration dates were 1998, and 2008 and pt was given this today 10/12/2009.  Dr. was notified of this error.
Vaccinated approx 11:15am on 6/22/07. Around 02:00am on 6/23/07 experienced severe chills and joint pain (ankles and wrist). Put on robe, turned off fan, no difference in chills. Unable to locate thermometer at this time. Went back to sleep around 04:45am. Around 06:00am Woke at with high fever, headache, nausea, and continued joint pain - took 800mg ibuprofen, removed excess blankets/covers. Continued fever and lightheadedness. Thermometer found, temperature taken at 12:00pm, temp = 100.2F. Continued 800mg ibuprofen q 8 hours x 3 additional doses. Fever resolved by 07:00am on 6/24/07.
Soreness at site of administration noted next day.  However, the site is on the back of the left arm, so patient didn't note redness until 7/15.  Fairly well circumscribed oval approx 1 1/2 x 2 1/2" at site of injection.
Pruritic blistering rash between digits of left hand, radiating to wrist beginning day after smallpox/anthrax vaccines; similar rash at right forearm/antecubitus, abdomen, left hip; much improved with use of hydrocortisone cream and otc antihistamines; no constitutional symptoms; father has psoriasis, pt with hx wintertime atopic dermatitis as child. Follow-up Information:  Description: eczema vaccinatum after primary dose vaccinia. Comment: permanent medical exemption from vaccinia.
Mild isolated lymph node swelling in ipselat axilla, noticed 1 week after immunization.
Sniffles and positive test 5 days after stopping Paxlovid; Sniffles and positive test 5 days after stopping Paxlovid; This spontaneous case was reported by a patient and describes the occurrence of RHINORRHOEA (Sniffles and positive test 5 days after stopping Paxlovid) and COVID-19 (Sniffles and positive test 5 days after stopping Paxlovid) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product NIRMATRELVIR, RITONAVIR (PAXLOVID) for COVID-19 treatment.    Patient had medical history but not reported.  Concurrent medical conditions included Drug allergy (Drug not reported).   On 25-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-May-2022, the patient started NIRMATRELVIR, RITONAVIR (PAXLOVID) (unknown route) at an unspecified dose. On 21-May-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced RHINORRHOEA (Sniffles and positive test 5 days after stopping Paxlovid). On an unknown date, the patient experienced COVID-19 (Sniffles and positive test 5 days after stopping Paxlovid). At the time of the report, RHINORRHOEA (Sniffles and positive test 5 days after stopping Paxlovid) and COVID-19 (Sniffles and positive test 5 days after stopping Paxlovid) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-May-2022, SARS-CoV-2 test: positive (Positive) Positive.         No concomitant medications were reported.  Patient was not taking any other medications/products within 2 weeks of starting COVID-19 treatment.  Patient previously received a COVID-19 Vaccine.  No treatment drugs were reported.  Company comment: This spontaneous case concerns a 31-year-old male patient with no relevant medical history, who experienced unexpected, non-serious adverse event of special interest Covid-19 which occurred at an unknown time with regards to the mRNA-1273 vaccination. The patient experienced rhinorrhea and retested positive after taking paxlovid. The outcome of the events was reported as resolving. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Sender's Comments: This spontaneous case concerns a 31-year-old male patient with no relevant medical history, who experienced unexpected, non-serious adverse event of special interest Covid-19 which occurred at an unknown time with regards to the mRNA-1273 vaccination. The patient experienced rhinorrhea and retested positive after taking paxlovid. The outcome of the events was reported as resolving. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
Sore upper arm, on day 8 arm became red, warm and hard . In following days redness spread out to almost elbow and shoulder. Treated with cephalexin. Now is resolved.
CHILLS; FATIGUE; This spontaneous report received from a patient concerned a 59 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808978, and expiry: UNKNOWN) dose was not reported, administered on 26-MAR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 26-MAR-2021, the subject experienced chills. On 26-MAR-2021, the subject experienced fatigue. On 16-APR-2021, Laboratory data included: Antibody test (NR: not provided) NEGATIVE. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills, and the outcome of fatigue was not reported. This report was non-serious.
Information has been received from a pharmacist concerning a female pt with a drug allergy to Ceftin who on 11/3/01 was vaccinated in the left deltoid with a dose of pneumococcal vaccine 23 polyvalent. On approx. 11/4/01, 24 hours post vax, the pt developed a red band around her left arm 1" below the injection site. The arm was swollen and painful. It was unknown if the pt sought medical attention. Additional information has been requested.
Hives, fever, sore arm for 4 + days.  Positive Covid test on January 23, 2021
I got light headed and felt like passing out about 3 to 5 minutes after the shot. Felt that way for about an hour after shot. Got Covid arm at injection site and sick with vertigo for two weeks after. After receiving the second shot on April 2, I didn?t react to the second dose like the first. Mild symptoms after second shot. Three weeks after second shot I suffered a Stroke, with extremely painful headache and with left side numbness in head, neck and painful left arm and numbness in left arm and leg
Patient was sitting in the post-vaccination chair, about 10 minutes after her vaccination time. She lost consciousness and fell to the floor. I instructed the technician to call 911 and went to the patient, who quickly regained consciousness. She sat back in the chair, and we gave her some water. She said she was feeling better when the EMT arrived.
Soreness at injection site; Moderate to severe fatigue for 2 days; This is a spontaneous report from a non-contactable consumer, the patient. A 28-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6200) via an unspecified route of administration in the arm left on 10Apr2021 at 10:30 (at the age of 28-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included THRIVE by Le-Vel Dietary Supplements for unknown indication from an unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the arm left on 13Mar2021 at 10:30 (at the age of 28-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 13:00, the patient experienced soreness at injection site and moderate to severe fatigue for 2 days. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event soreness at injection site and moderate to severe fatigue for 2 days was resolved on an unspecified date in Apr2021.  No follow-up attempts are possible. No further information is expected.
Telephone call from mother 11 AM 12/13/2001, states child has his white bumps all over his body. Denies any elevated temp or other health problems. History of eczema. 12/14/2001 Temperature confirmed with mother. Took child to quick care 12/13/2001. States MD advised not a reaction to MMR.
48 hrs febrile, 36 of which were over 101 but less than 102 joint and muscle pain (severe to moderate) nausea with vomiting headache for 48 hours HUGE flare 7mm across around injection site with itching and swelling
I got sicker than a dog within hours; Initial information received on 11-Dec-2020 regarding an unsolicited valid non-serious case received from a consumer via social media.  This case involves an unknown age patient for who got sicker than a dog within hours (illness), while he/she received vaccine Influenza Vaccine.  The patient's past medical history, medical treatment(s), vaccination(s), concomitant medications and family history were not provided.  On an unknown date, the patient received a dose of suspect Influenza Vaccine produced by unknown manufacturer lot number not reported via unknown route in unknown administration site, for Prophylactic vaccination.  On an unknown date, (Unknown latency) following the administration of Influenza Vaccine, the patient got sicker than a dog within hours (illness).  No laboratory data was reported.  It was not reported if the patient received a corrective treatment.  The event outcome was reported as Unknown.  No further information was reported.
PT WAS GIVEN AN ADULT DOSE OF HEP A VACCINE.  NO ADVERSE EVENT
covid arm; Itchy; red welt; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (covid arm), VACCINATION SITE PRURITUS (Itchy) and VACCINATION SITE URTICARIA (red welt) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (covid arm), VACCINATION SITE PRURITUS (Itchy) and VACCINATION SITE URTICARIA (red welt). At the time of the report, VACCINATION COMPLICATION (covid arm), VACCINATION SITE PRURITUS (Itchy) and VACCINATION SITE URTICARIA (red welt) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication information was reported No treatment medication information was reported   Reporter did not allow further contact
registered in the Pregnancy Registry; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (registered in the Pregnancy Registry) in a 24-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     The patient's past medical history included Pregnancy (Outcome: Live,full term birth) from May 2015 to 19-Jan-2016. Concomitant products included PARACETAMOL (TYLENOL A) for an unknown indication.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 05-Feb-2021 and the estimated date of delivery was 11-Nov-2021. On 23-Mar-2021, the patient experienced EXPOSURE DURING PREGNANCY (registered in the Pregnancy Registry). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  sixth week of the pregnancy.  On 23-Mar-2021, EXPOSURE DURING PREGNANCY (registered in the Pregnancy Registry) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Mar-2021, Pregnancy test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Left axillary Lymph node got very swollen..painful 2-3 days after Moderna booster.  I have previously only had the Pfizer COV ID vaccine. My left deltoid was very painful and I was hoping it was just related to that? However? It almost caused me to have a axillary node biopsy by a surgeon. I was very alarmed that I had lymphoma or melanoma.